ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

NCI, Litton Open Talks On Frederick Contract

February 6, 1976

Scientists Brief Writers On Progress In Cancer Research

April 18, 1975

Ruckdeschel To Direct Nevada Cancer Institute

February 6, 2009

In Brief: Loberg Resigns From Bristol-Myers Squibb; Bloomfield Heads Cancer Center At Ohio State

February 14, 1997

Stop Suffering And Death “All Around Us”? Von Eschenbach Speeches At FDA Omit 2015 Goal.

February 17, 2006

Scientific Process

September 25, 1998